Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients' treatment significantly reduced the risk of major ...

Add Yahoo as a preferred source to see more of our stories on Google. There are four main risk factors that are present in 99 per cent of heart attack victims (Getty Images/iStockphoto) The research ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration of a heart Heart attacks and strokes rarely occur without warning. According to health data from more than 9 million ...

Tackling hypertension, high cholesterol may help prevent heart attack, stroke, new research confirms. Image credit: Raymond Forbes LLC/Stocksy Researchers estimate that about 85% of all cardiovascular ...

Heart attacks don’t always look the same — and a new study from Mayo Clinic highlights the key differences between how they affect men and women. The most common cause of heart attacks overall is ...

Cardiologists have long warned that heart attacks and strokes rarely arrive without some kind of signal, yet those signals are often subtle enough to dismiss as fatigue, indigestion or a pinched nerve ...

Findings that evolocumab significantly reduced the risk of major adverse CV events in adults at high CV risk without prior heart attack or stroke vs placebo. Topline data were announced from a phase 3 ...